Physician profile
Babak Kosari
NPI 1639101793
$33,075.68
in general payments reported to CMS, 2019-2025
12 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $55.56 · 2021: $347 · 2022: $212 · 2023: $1,461 · 2024: $49.13 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $30K · Travel and Lodging: $913 · Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $30,398.00 |
| Travel and Lodging | $912.58 |
| Food and Beverage | $612.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $30,950.71 | 2019-2025 | Grafix Pl, Grafix, Healicoil |
| Stryker Corporation | $1,439.48 | 2019-2023 | Prostep, Prophecy |
| Angiodynamics, INC. | $164.48 | 2021-2022 | |
| Abbvie INC. | $124.45 | 2023 | |
| Cardiovascular Systems INC. | $123.87 | 2021 | |
| Horizon Therapeutics Plc | $114.99 | 2021 | |
| Osiris Therapeutics INC. | $51.36 | 2019 | |
| Micromed INC | $32.34 | 2021 | |
| Integra Lifesciences Corporation | $24.06 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.60 | 2022 | |
| Orthofix Medical, INC. | $15.19 | 2025 | Physio-Stim |
| Bsn Medical INC | $15.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Kosari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.